Pneumococcal conjugate vaccines for preventing acute otitis media in children
Updated review (11 trials; n=60,733) found administration of licenced 7‐valent vaccine with CRM197 as carrier protein and 10‐valent PCV conjugated to protein D during early infancy is associated with large relative risk reductions in pneumococcal acute otitis media.
Source:
Cochrane Database of Systematic Reviews